- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04251338
Delayed Visual Maturation: Outcome and Predictive Factors (DVM)
May 7, 2020 updated by: Universitaire Ziekenhuizen KU Leuven
The objectives of the study are to describe the developmental outcome in a population of children with delayed visual maturation.
Study Overview
Status
Completed
Conditions
Detailed Description
description of the developmental outcome of children with delayed visual maturation.
Study Type
Observational
Enrollment (Actual)
71
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leuven, Belgium, 3000
- Universitaire Ziekenhuizen Leuven
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 14 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
patients seen in UZ Leuven between 1998 and 2016 with diagnosis of delayed visual maturation who meet the inclusion criteria.
Description
Inclusion Criteria:
- Infants (male or female) with suboptimal/absent visual contact at the age of ≥3 months, without other known general developmental delay at the time diagnosis of delayed visual contact and without anatomic ocular abnormalities at the initial ophthalmological examination.
Exclusion Criteria:
- Children with known underlying psychomotor developmental delay or epilepsy at first ophthalmic consultation.
- Children with ophthalmic (anatomical) abnormalities that explain delayed visual maturation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
|---|
|
delayed visual maturation
children with delayed visual maturation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
delayed visual maturation.
Time Frame: 1998-2016
|
the prevalence of developmental problems in children with delayed visual maturation.
|
1998-2016
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Level of development
Time Frame: 1998-2016
|
by questionnaire:type of education/school , problems with writing, mathematics: yes or no
|
1998-2016
|
|
Fine and gross motor skills
Time Frame: 1998-2016
|
by questionnaire: physiotherapy needed yes or no
|
1998-2016
|
|
ophthalmological problems
Time Frame: 1998-2016
|
by questionnaire : visual problems, wearing glasses?
taped eyes?
|
1998-2016
|
|
Visual acuity
Time Frame: 1998-2016
|
assested at the last consultation indicated in Snellen
|
1998-2016
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ingele Casteels, PhD, UZ Leuven
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 3, 2019
Primary Completion (Actual)
February 10, 2020
Study Completion (Actual)
February 10, 2020
Study Registration Dates
First Submitted
December 31, 2019
First Submitted That Met QC Criteria
January 30, 2020
First Posted (Actual)
January 31, 2020
Study Record Updates
Last Update Posted (Actual)
May 8, 2020
Last Update Submitted That Met QC Criteria
May 7, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- S62961
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Delayed Visual Maturation
-
Central Hospital, Nancy, FranceCompletedDelayed Visual Maturation
-
Cairo UniversityEnrolling by invitationSkeletal MaturationEgypt
-
Chinese University of Hong KongRecruiting
-
Sheffield Children's NHS Foundation TrustCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Universitair Ziekenhuis BrusselRecruiting
-
Universitair Ziekenhuis BrusselCompletedIn Vitro Maturation of OocytesBelgium
-
Mỹ Đức HospitalCompleted
-
Hung Vuong HospitalDioseve Inc.Not yet recruitingInfertility | Oocyte MaturationVietnam
-
The Second Affiliated Hospital of Kunming Medical...CompletedOocyte Maturation FailureChina